Scivision Biotech Inc produces medical Hyaluronic Acid using fermentation biotechnology. The company products include Hya-Dermis and Hya-Joint injection, skin care series and health food.

The Company Is Invited To Participate In The Black
Stone Financial "Strategic Taiwan Investment Forum"
Institutional Investor Conference

To Announce The Record Date Of Common Stocks
Transferred From The 2nd Domestic Unsecured
Convertible Bond For The Third Quarter Of 2024

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Scivision Biotech (1786 TT)

The Company Is Invited To Participate In The Black Stone Financial "Strategic Taiwan Investment Forum" Institutional Investor Conference

To Announce The Record Date Of Common Stocks Transferred From The 2nd Domestic Unsecured Convertible Bond For The Third Quarter Of 2024

Announcement Of Board Meeting Approved The Consolidated Financial Statements For The Third Quarter Of 2024.

Announcement The Expected Date Of The Board Of Directors Meeting To Approve 2024 Third Quarter Consolidated Financial Report.

Clarification Of Media Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)